Abstract
Faithful genome duplication requires regulation of origin firing to determine loci, timing and efficiency of replisome generation. Established kinase targets for eukaryotic origin firing regulation are the Mcm2-7 helicase, Sld3/Treslin/TICRR and Sld2/RecQL4. We report that metazoan Sld7, MTBP (Mdm2 binding protein), is targeted by at least three kinase pathways. MTBP was phosphorylated at CDK consensus sites by cell cycle cyclin-dependent kinases (CDK) and Cdk8/19-cyclin C. Phospho-mimetic MTBP CDK site mutants, but not non-phosphorylatable mutants, promoted origin firing in human cells. MTBP was also phosphorylated at DNA damage checkpoint kinase consensus sites. Phospho-mimetic mutations at these sites inhibited MTBP’s origin firing capability. Whilst expressing a non-phospho MTBP mutant was insufficient to relieve the suppression of origin firing upon DNA damage, the mutant induced a genome-wide increase of origin firing in unperturbed cells. Our work establishes MTBP as a regulation platform of metazoan origin firing.
Similar content being viewed by others
Introduction
The eukaryotic genome must be duplicated completely and accurately to guarantee inheritance of stable genomes. Origin firing needs to be efficient and appropriately placed and timed to avoid replication stress and genetic instability. Failure of origin firing regulation can generate replication stress1,2, but has been little investigated. In principle, failure of firing regulation can result in low-efficiency firing (under-firing), excessive firing or mis-localised ectopic firing. Global and local under-firing is expected to generate non-replicated gaps by increased inter-origin distances3,4,5. Global under-firing also reduces the overall number of replisomes, which results in increased replication fork speed that was proposed to generate replication stress6. Excessive origin firing may deplete cells of back-up origins required to fully replicate the genome in adverse replication conditions and in normal conditions in specific difficult-to-replicate genomic locations2. Excessive firing could also result in replication gaps through competition of origins for limiting origin firing factors7,8,9. Ectopic origin firing may generate replication stress by increased collision of replication machines with chromatin processes such as transcription10,11.
The main regulation step of origin firing is pre-initiation complex (pre-IC) formation as exemplified by classic cell cycle and DNA damage checkpoint regulations of replication initiation in yeast2,12. Pre-IC formation is the first step of converting pre-replicative complexes (pre-RCs), the replicative helicase in a chromatin-loaded inactive form, into active replisomes. In yeast, rising activities of Dbf4-dependent kinase (DDK) and cyclin-dependent kinase (CDK) in S phase mediate the assembly of pre-initiation complexes (pre-ICs) on pre-RCs, comprising Sld3-Sld7 (both form a constitutive complex), Sld2, Dpb11, DNA polymerase epsilon, Cdc45 and GINS8,13,14,15,16,17,18,19,20. Sld3-Sld7, Sld2 and Dpb11 dissociate and the active Cdc45-Mcm2-7-GINS-polymerase epsilon replicative helicase and finally mature replisomes form21,22,23,24. The exact role of Sld7, the yeast orthologue of MTBP25,26, has not been elucidated. Sld7 is important but not essential for origin firing in yeast27. It binds to Sld3 using its N-terminus and forms Sld7 homo-dimers using its extreme C-terminal domain28.
Sld7 is not considered a highly regulated factor, unlike the critical CDK and DDK substrates Sld3, Sld2 and pre-RCs15,18,19,29. Moreover, the Rad53 DNA damage kinase phosphorylates both Dbf4 and Sld3 to inhibit the firing of late origins to avoid excessive replication of damaged DNA templates30,31,32.
In addition to the described fundamental regulations by the cell cycle and the DNA damage checkpoint, fine tuning the levels and activities of pre-IC factors is critical for origin firing timing and replication fidelity7,8,33,34,35. For example, the DNA damage kinase Mec1 has basal activity in the absence of exogenous DNA damage36, and the ATR-dependent kinase pathway in metazoa was found to attenuate origin firing in the absence of induced DNA damage37,38.
In metazoa, the detailed molecular processes of pre-IC formation are unknown. All core yeast pre-IC factors have orthologues in metazoa25,26,39,40,41,42,43,44. Also conserved is the essential role of Treslin/TICRR and TopBP1, metazoan Sld3 and Dpb11, in mediating CDK-dependent S phase-specific origin firing45,46. Like Sld3, Treslin/TICRR appears to be a target to fine-regulate origin firing47,48,49. MTBP is essential for replication in human cells and Xenopus egg extracts26,50. The N-terminal Sld7-homologous domain (S7M-N, for Sld7-MTBP N-terminal domain) (Fig. 1) facilitates replication through binding to Treslin/TICRR in human cells25. Its C-terminal Sld7-homologous domain (S7M-C, Sld7-MTBP C-terminal domain) may mediate origin firing through homo-dimerization25,28. The metazoa-specific MTBP middle domain has multiple roles in replication, one of which involves interaction with the Cdk8/19-cyclin C kinase that is required to prevent under-replication by unknown mechanisms25.
MTBP was originally identified using yeast-two-hybrid experiments as a binder of the Mdm2 protein that helps Mdm2 degrade p5351,52. Since then MTBP has been implicated in mitosis53, cell migration54, transcription55 and cancer formation56,57. The relevance of these findings for MTBP’s role in replication remains unexplored.
We here put MTBP into the spotlight as an origin firing regulation platform specifically in metazoa. It is targeted by at least three kinase pathways, Cdk8/19-cyclin C25, cell cycle CDK and by phosphorylation at DNA damage kinase consensus sites. Eliminating MTBP regulation through phosphorylation changed origin firing frequency in normal cell growth conditions. Our insight highlights that understanding how metazoa replicate their vast genomes accurately and completely requires considering metazoa-specific origin firing regulations in addition to those widely conserved.
Results
MTBP is posttranslationally modified
Searching online databases revealed that MTBP is modified by phosphorylation, ubiquitylation, SUMOylation and methylation (phosphosite.org). Modifications are particularly numerous in the C-terminal half of MTBP containing the metazoa-specific central and the S7M-C regions (Fig. 1). Initial experiments showed that mutations eliminating a methylation site (lysine 739) or eight lysines reported to be ubiquitylated (positions 570, 591, 604, 608, 627, 630, 642, 752)58,59,60,61,62 or SUMOylated (752) had no effect on the capability of MTBP to support incorporation of the nucleotide analogue BrdU in Hela cells (Supplementary Information Fig. S1), showing that these modifications are not essential for overall DNA synthesis.
We realised that MTBP is phosphorylated at consensus sites for CDK and DNA damage checkpoint kinases. All six CDK consensus sites (pS/T-P) (Fig. 1) in MTBP were reported to be phosphorylated63,64,65,66. Out of the 23 checkpoint kinase consensus sites (four ATM/R sites (S/T-Q) and 19 Chk1/2 sites (R/KxxS/T)) in MTBP six sites in the heavily modified C-terminus were found phosphorylated (Fig. 2A). One of them is a consensus site for the ATR/M kinases and five for Chk1/258,67,68. We decided to investigate the role of CDK and checkpoint kinase sites further, because these pathways are known regulators of origin firing.
MTBP phosphorylation at checkpoint kinase consensus sites inhibits genome replication
Recombinant Chk1 phosphorylated recombinant MTBP, as determined by incorporation of radioactive phosphate from γ-32P-ATP into recombinant MTBP (Fig. 2B). We did not find evidence for DNA damage induction of the reported MTBP phosphorylation in 293T and Hela cells using phospho-peptide mass spectrometry and phospho-specific antibodies. This suggests that this phosphorylation is DNA damage independent or that it is effectively removed by cellular phosphatases.
To test if phosphorylation of MTBP at checkpoint kinase consensus sites regulates origin firing we generated non-phosphorylatable and phospho-mimetic mutants by exchange to alanine (A) or aspartate (D), respectively. Because mutating all 23 sites (MTBP-23A/D) lowered expression levels (Supplementary Information Fig. S2), perhaps due to destabilising protein folding, we focused on mutants with 14 exchanges (MTBP-14A/D) in the heavily modified middle and C-terminal MTBP regions (Fig. 2A). MTBP-14A/D expressed to the same levels as MTBP-WT (Supplementary Information Fig. S2). To assess the replication-inducing capacity of these mutants, we used RNAi to replace endogenous MTBP with siRNA-resistant mutants using isogenic Hela cell FlipIn cell lines, as described25,50 (Supplementary Information Fig. S3). Overall DNA synthesis was measured by flow cytometry after pulse-labelling cells with 5-Bromo-2′-deoxyuridine (BrdU) in combination with staining double stranded DNA by propidium iodide (PI). Cells expressing siRNA-resistant wild type MTBP (MTBP-WT) transgene showed normal BrdU-PI profiles regardless of treatment with control (siCtr) or MTBP siRNA (siMTBP) (Fig. 2C–E). In contrast, cells expressing MTBP-14D and no-transgene control cells had strongly reduced replication signals upon siMTBP treatment to 39% and 27%, respectively, compared to 87% with MTBP-WT (Fig. 2C,D). MTBP-14D and control cells also had increased G2/M populations with a concomitant dramatic drop of the G1 population (Fig. 2E). Flow cytometry-determined G2/M populations often increase upon compromising replication as a consequence of delays in G2 and M phases. The defects with MTBP-14D reflected an effect of phosphorylation at these sites rather than unspecific MTBP inactivation due to the mutations, because MTBP-14A behaved like MTBP-WT (Fig. 2D,E). Expression levels of MTBP-14D, 14A and WT were similar (Fig. 2F). We then separated the mutations of MTBP-14A/D. Mutating the four ATR/M sites to D (MTBP-4D), but not to A (4A) (Fig. 2A), partly suppressed replication (Fig. 2C–F). Mutating three ATR sites (3D) and mutating all ten Chk1 sites to D (10D) (Fig. 2A) had moderate consequences if any (Fig. 2D,E Supplementary Information Fig. S4).
We conclude that phosphorylation at ATR/M and Chk1/2 consensus sites of MTBP cooperate to inhibit replication.
Origin firing is inhibited by MTBP phosphorylation at checkpoint kinase consensus sites
We next tested if MTBP phosphorylation at the checkpoint kinase sites inhibits replication by suppressing origin firing. To test if specifically the origin firing step is inhibited in MTBP-14D expressing cells, we isolated chromatin from siRNA-treated control cells or cells after RNAi-replacement of endogenous MTBP with MTBP-WT or 14D. Anti-Mcm2 immunoblotting served as a marker for pre-RCs and anti-Cdc45 for replisomes (origin firing). Control cells confirmed that MTBP siRNA specifically suppressed origin firing but not pre-RC formation50 (Fig. 3A). siMTBP-treated MTBP-WT and 14D expressing cells showed similar levels of pre-RCs, but MTBP-14D had Cdc45 levels that were as low as with siMTBP-treated control cells, indicating that phosphorylation at the 14 checkpoint kinase sites suppresses origin firing.
MTBP-14D is rescued by fusing a homodimerization domain, like deletion mutants of the Sld7-homologous C-terminal domain
We next asked how MTBP phosphorylation inhibits MTBP’s replication activity. We first tested if the inhibition of replication in MTBP-14D cells is an indirect consequence of the MTBP-14D protein activating the ATR-Chk1 DNA damage checkpoint that is known to inhibit origin firing. Western blotting against the ATR substrate site phospho-S345-Chk1 showed moderately (compared to HU treatment) but reproducibly increased ATR signalling in cells expressing MTBP-14D (Fig. 3B, Supplementary Information Fig. S5) (the non-CDK binding mutant MTBP-Cdk8bm25 was used here as a control because MTBP-14D/A do not strongly bind Cdk8/19-cyclin C (see below)). However, the checkpoint signal was not specific to MTBP-14D expression, because no-transgene control cells showed similarly increased phospho-S345-Chk1 signals upon siMTBP treatment, suggesting that the checkpoint is activated as a consequence of severely compromised DNA replication. We then checked if ATR inhibition by the chemical compound VE-821 relieves the block of replication in MTBP-14D cells. Although VE-821 mildly increased replication in unperturbed cells, indicating basal checkpoint activity even in normal growth conditions, VE-821 was not particularly effective in restoring replication in MTBP-14D expressing cells (Fig. 3C, Supplementary Information Fig. S5). In contrast, VE-821 effectively relieved the block of origin firing upon ionising radiation (discussed below). Thus, ATR signalling is not required for replication inhibition by MTBP-14D, which is consistent with the model that checkpoint site phosphorylation of MTBP directly inhibits replication origin firing.
We then tested which molecular activity of MTBP is inhibited in MTBP-14D. Figure 3D shows that MTBP-14D is proficient in the essential binding to Treslin/TICRR. Binding to Cdk8/19-cyclin C was compromised in both MTBP-14A and 14D (Fig. 3D). The interaction with Cdk8/19-cyclin C is required to complete DNA replication but has little effect on overall BrdU incorporation25, indicating that inability to interact with the kinase is insufficient to explain the inactivity of MTBP-14D.
We then tested if phosphorylation inhibits the MTBP-S7M-C domain. We reported earlier that the S7M-C domain supports replication probably by mediating MTBP homodimerization based on the finding that MTBP mutants that lack S7M-C (MTBP-∆C150 and ∆C80), which show partly reduced replication inducing activity, were rescued by fusing the dimerising GST but not the non-dimerising GFP25 (Fig. 3E,F). MTBP-14D and 4D, but not the Treslin/TICRR non-binding MTBP-5m, were rescued by GST, whereas fusing GFP had no effect (Fig. 3E,F, Supplementary Information Fig. S6). The observation that specifically the phospho-mimetic MTBP mutants show the same rescue behaviour by GST fusion as mutants of the S7M-C homodimerization domain suggested that the phosphorylation may inhibit MTBP by counteracting the activity of the S7M-C domain. The inhibitory effect of 14D on replication was stronger than that of deleting S7M-C. Phospho-mimicry must therefore inhibit additional activities required for normal replication. These inhibited activities do not include the binding to Treslin/TICRR (Fig. 3D). As a side note, the rescue of MTBP-14D by GST fusion provides additional evidence that the 14 mutations do not inactivate MTBP by misfolding.
MTBP phosphorylation at the 14 checkpoint kinase consensus sites is dispensable for origin firing suppression upon DNA damage, but required for normal origin firing rates in unperturbed cells
MTBP phosphorylation at checkpoint kinase sites could help inhibit origin firing upon DNA damage. Failure to inhibit firing results in radio-resistant DNA synthesis (RDS). If bypassing MTBP inhibition was sufficient to relieve the block of origin firing upon DNA damage expressing MTBP-14A should induce RDS. Control experiments showed that BrdU-PI flow cytometry of cells treated with ionising radiation (IR) was able to monitor ATR-dependent (VE-821-sensitive) origin firing inhibition (Supplementary Information Fig. S7). Expressing MTBP-14A did not result in RDS (Fig. 4A). Thus, bypassing MTBP phosphorylation did not relieve origin firing inhibition upon DNA damage. This indicates that other origin firing inhibition pathways are sufficient to prevent RDS, but does not exclude a contribution of MTBP phosphorylation.
We asked next if MTBP phosphorylation at checkpoint kinase consensus sites has a DNA damage-independent origin firing regulation role. We used DNA combing to test if expression of MTBP-14A increases origin firing frequency in cells growing in the absence of exogenous DNA damage. MTBP-14A cells showed a reduction of average inter-origin distance (IOD) by 32% from 122 kbp of MTBP-WT expressing cells to 83 kbp in the mutant, indicating elevated firing (Fig. 4B,C). The IOD reduction was not due to the inability of MTBP-14A to bind Cdk8/19-cyclin C because the MTBP-Cdk8bm mutant, which cannot bind Cdk8/19-cyclin C due to seven amino acid exchanges in the metazoa-specific middle domain25, showed a normal IOD (Fig. 4C). The reduced IOD with MTBP-14A also did not result from a change of the DNA damage checkpoint signalling status, which could involve dormant origin firing, as determined by anti-phospho-S345-Chk1 western blotting (Fig. 3B, Supplementary Information Fig. S8), and also not from decreased passive replication of origins due to slower forks, because average fork speed was normal in MTBP-14A cells (Supplementary Information Fig. S8). In summary, the finding that MTBP-14 cells fire more origins is consistent with the model that the 14 alanine mutations bypass an attenuation mechanism of origin firing in normal growth conditions.
As described, excessive origin firing could result in replication stress. However, the observations that neither elevated basic levels of phospho-S345-Chk1 in normally growing MTBP-14A cells was detected (Fig. 3B) nor an elevated response to titrating hydroxyurea (Supplementary Information Fig. S8) argued against significant replication stress inMTBP-14A cells.
Phosphorylation of MTBP at its six CDK consensus sites impacts replication origin firing
Previous evidence suggested that MTBP is phosphorylated in lysates from mitotic cells, as judged by a gel shift upon nocodazole arrest in comparison with unsynchronised cells and cells from G1 phase25,50. We found that MTBP and Treslin/TICRR, which is a heavily phosphorylated cell cycle CDK substrate45,50, migrated faster in lysates of nocodazole-arrested cells upon treatment of the lysate with lambda phosphatase (Fig. 5A, lanes 3,8; Supplementary Information Fig. S9). This showed that the reported gel shift was indeed due to phosphorylation. Treatment with low concentrations of the CDK inhibitor RO-3306 (lane 4) effectively reversed the MTBP and Treslin/TICRR gel shifts (Supplementary Information Fig. S9). Low RO-3306 concentrations effectively inhibit Cdk1, which constitutes M-phase CDK kinases (M-CDK), but not Cdk2-dependent kinases. Also the Cdk1/2 inhibitor roscovitine (lane 6), but not the Cdk8/19 inhibiting senexin A (lane 7), partly reversed the gel shift (Supplementary Information Fig. S9). Less pronounced phosphatase-sensitive gel shifts of MTBP and Treslin/TICRR were also detectable in cells synchronised in S phase by a 4 h release from a nocodazole-thymidine arrest (Supplementary Information Fig. S9). However, kinase inhibitor-treated samples were inconclusive for MTBP due to the lower degree of gel shift in S phase cells. These experiments suggested that M-CDK phosphorylates MTBP, and that MTBP is also phosphorylated in S phase, although the contributions of S-CDK and Cdk8/19-cyclin C remain unclear.
To test if S-CDK can phosphorylate MTBP at the six CDK consensus sites in the protein we used recombinant Cdk2-cyclin A for in vitro kinase experiments. Figure 5B shows that recombinant MTBP indeed incorporated radioactive phosphate upon incubation with recombinant Cdk2-cyclin A. The kinase did not phosphorylate GFP-3Flag-tagged MTBP isolated from lysates of transfected 293T cells when all six CDK consensus sites were mutated to alanine (MTBP-6A) (Fig. 5C(i),(ii)), showing that the phosphorylation depends on the six CDK consensus sites. Together, these experiments suggested that MTBP is a substrate of M and S-CDK kinases. M-CDK phosphorylates MTBP in mitotic cells, whereas the contribution of S-CDK to MTBP phosphorylation in S phase cells remains open.
We found evidence that MTBP can also be phosphorylated by Cdk8-19-cyclin C. Incubating beads that contained MTBP-3Flag-GFP immunoprecipitated from cell lysates with γ-32P-ATP we noticed that a kinase activity co-purified that produced a band at the size of MTBP-3Flag-GFP (Fig. 5D). This kinase activity was only detectable in long exposures, which is why it was not evident in similar kinase experiments involving Cdk2-cyclin A (Fig. 5B). The co-purifying activity depended on the binding of MTBP to Cdk8/19-cyclin C since the signal was undetectable with MTBP-Cdk8bm that cannot bind to Cdk8/19-cyclin C (Fig. 5E). To improve signal intensity, we co-transfected Cdk8-cyclin C together with MTBP mutants for the following experiments. MTBP phosphorylation was eliminated by the Cdk8/19-cyclin C inhibitor senexin A (Fig. 5F). Also the CDK site mutant MTBP-6A nearly abrogated the signals (Fig. 5F). Because MTBP-6A binds Cdk8/19-cyclin C less well than MTBP-WT (Fig. 5F(i)) we tested a phospho-mimetic aspartate mutant of MTBP (MTBP-6D) that binds Cdk8/19-cyclin C normally. Quantification of three experiments showed that MTBP-6D incorporated 32P detectably, but 2.3 times less than MTBP-WT (Fig. 5F(ii)). These experiments suggested that Cdk8/19-cyclin C phosphorylates MTBP on the six CDK consensus sites and also on non-CDK consensus sites. Whether Cdk8/19-cyclin C also phosphorylates MTBP in cells remains open, because senexin A treatment had only little if any effect on the MTBP phospho-shift in M phase cells (Fig. 5A; Supplementary Information Fig. S9).
We then investigated the relevance of MTBP phosphorylation at CDK consensus sites on the replication function of MTBP by analysing the phospho-mimetic and non-phosphorylatable MTBP-6D and the MTBP-6A mutants. Neither mutant had overt effects on BrdU incorporation, cell cycle distribution and expression levels, indicating that MTBP phosphorylation by CDK is not essential for replication (Fig. 6A–C). DNA combing showed that MTBP-6D reduced the IOD by 38% from 122 kbp (MTBP-WT) to 76 kbp (Fig. 6D). MTBP-6A did not affect IOD. We then tested whether the increased origin firing (decreased IOD) in MTBP-6D cells could be an indirect consequence of replication stress-induced dormant origin firing. However, we found no evidence for elevated checkpoint signalling in MTBP-6D cells, as basic phospho-S345-Chk1 levels and the response to increasing hydroxyurea concentrations were indistinguishable from MTBP-WT cells (Supplementary Information Fig. S8). Together, these experiments with MTBP CDK site mutants indicated that more origins fired in cells where phosphorylation was mimicked. This phenotype could reflect a direct or indirect effect of CDK site phosphorylation on origin firing frequency. Average replication fork speed was normal in the MTBP-6D mutant (Supplementary Information Fig. S8).
We conclude from Figs. 1–6 that MTBP phosphorylation by several kinase pathways controls origin firing in normally growing cells.
Discussion
Understanding the cellular and molecular mechanisms that guarantee that origin firing occurs with sufficient efficiency at the right time in the right place is a central biological question as it is key to inheriting stable genomes. Understanding the consequences of failure of this firing control is important both biologically and from the perspective of human health, because DDK inhibitors that inhibit firing are considered as cancer therapeutics69,70.
MTBP is a regulation focus of origin firing
Our insight of MTBP as a focus of kinase regulation places MTBP among the more established origin firing regulators in metazoa. Like yeast Sld7, MTBP is a core factor of pre-IC formation25,50. Pre-IC formation is well-placed for origin firing regulation, as it is the most upstream essential firing step14,17,20. In yeast and metazoa, other pre-IC proteins, namely Sld3/Treslin/TICRR, Sld2/RecQ4, the Mcm2-7 helicase and Dbf4, are known to mediate fundamental cell cycle and DNA damage checkpoint-mediated origin firing regulation and fine tuning of origin firing, involving a variety of molecular mechanisms that control levels and activities of these pre-IC factors7,8,15,18,19,30,34,35,44,45,46,47,48,49,71,72,73,74.
Our GST-fusion experiments (Fig. 3E,F) suggested that MTBP regulation may occur by counteracting the S7M-C domain that probably mediates MTBP homo-dimerization25,28. MTBP dimerization may help mediate bi-directionality of replication by ensuring that both Mcm2-7 hexamers of pre-RCs, but never only one, are converted into replisomes. S7M-C has also been suggested to have DNA binding activity26.
MTBP phosphorylation may contribute to establishing origin firing homeostasis
What are the cellular mechanisms of regulating genome replication by MTBP phosphorylation at checkpoint kinase and CDK consensus sites?
The genome-wide attenuation of origin firing by MTBP phosphorylation at checkpoint kinase consensus sites supports the concept that origin firing regulation guarantees firing homeostasis. Origin firing homeostasis depends on the right propensity of the genomic origins to fire in order to avoid replication stress by excessive firing or by under-firing. We could not identify which kinase executes phosphorylation at the 14 checkpoint kinase consensus sites in cells. However, previous observations that DNA damage checkpoint kinases control the efficiency of origin firing in unperturbed conditions37,38 indicated that the increased firing in cells expressing the MTBP-14A mutant may result from bypassing MTBP inhibition by a basal global activity of DNA damage checkpoint kinases in the absence of exogenous DNA damage.
As an origin firing homeostasis mechanism MTBP phosphorylation could go hand in hand with other mechanisms that control overall levels of origin firing factors and their firing promoting activity. For example, pre-IC proteins were shown to be limiting for origin firing in vertebrates and yeasts and specific control mechanisms exist to determine their levels7,9,34,35. Moreover, fast recycling dynamics of such limiting pre-IC factors from fired origins could help guarantee that sufficient pre-IC factors are available for firing origins downstream. Yeast Sld2, Sld3 and Dpb11 are presumably present upon origin firing in a CDK phosphorylation-dependent complex17,18,19 and may require active disassembly and extraction from the activated Mcm2-7 helicase to fire the next origin.
Origin firing homeostasis may also depend on the balance between firing-regulating kinases and phosphatases. Rif1 in association with protein phosphatase 1 were proposed to inhibit origin firing by counteracting DDK phosphorylation75,76,77,78,79. Specific kinase-phosphatase balance mechanisms may also exist for other firing-regulating kinases. Rising S-CDK activity levels towards late S phase could tip the respective balance to fire late origins with low intrinsic firing propensity.
Intuitively, an imbalance of origin firing homeostasis by a decrease in firing propensity should result in less efficient firing and replication stress through large IODs that result in non-replicated gaps. Our observation that depletion of MTBP and replacement of endogenous MTBP by MTBP-14D induce DNA damage signalling support this idea, confirming similar earlier findings6 (Fig. 3B and Supplementary Information Figs. S5, S8). Interestingly, firing moderately more origins than normal by expressing MTBP-14A and MTBP-6D did not result in detectable replication stress in Hela cells, suggesting that a slight imbalance of origin firing homeostasis by increased origin firing propensity is not sufficient not cause major problems to unperturbed cells.
Potential role of MTBP phosphorylation by Cdk8/19-cyclin C and cell cycle CDK in origin firing regulation
Our observation that MTBP-6D cells showed increased origin firing is consistent with this phosphorylation promoting origin firing directly or indirectly. Because MTBP-6A cells showed no decrease in overall firing and BrdU incorporation, a role of this phosphorylation in Hela cells, perhaps a role in controlling a specific subset of origins, remains unproven.
We reported earlier that preventing Cdk8/19-cyclin C binding to MTBP increased replication stress signs, whilst affecting BrdU incorporation mildly25. We found here that the six CDK consensus sites in MTBP (or a subset of them) can be phosphorylated by Cdk8/19-cyclin C co-purified with MTBP, but that this kinase also phosphorylates non-CDK consensus sites in this assay, which remain to be mapped. Perhaps, the recruitment of Cdk8/19-cyclin C by tight binding to MTBP enables the kinase to phosphorylate non-consensus sites. Given that Cdk8/19-cyclin C is a transcriptional CDK it is tempting to speculate that this kinase phosphorylates MTBP to coordinate transcription with replication to avoid genetic alterations11.
Cell cycle CDK phosphorylation of MTBP occurred in mitotic cells. Thus, cell cycle CDK phosphorylation of MTBP may serve mitotic roles53 apart from potential roles in origin firing.
Our establishing of MTBP as a platform of origin firing regulation shows that understanding how metazoa facilitate origin firing regulation to faithfully inherit their genetic information will require investigating MTBP along-side the previously established firing regulators.
Materials and methods
For all immunoblots blots, radiograms and other protein gels presented in main and supplemental figures, uncropped images are shown in Supplementary Fig. S11.
Cell culture
Cell culture conditions and generation of stable HeLa Flip-In T-Rex cell lines (kind gift from G Muller-Newen80) using pcDNA5 derivates were described25.
Transient transfection of 293T cells
Transient 293T (ATCC CRL-11268) cell transfections were conducted as described using CaCl225 or using PEI (polyethylenimine) according to a protocol kindly shared by David Cortez’ lab. 4 µg plasmid DNA in 100 µl DMEM without serum were combined with 24 µl PEI (1 mg/ml) and incubated for 15 min before addition to 5 × 106 cells on a 10 cm dish. Transfected cells were used 72 h post transfection. For subsequent immunoblotting of whole cell lysates harvested cells were boiled in Laemmli loading buffer.
RNAi
RNAi using RNAiMax (Life Technologies) was described25. The following siRNAs were used: siCtr/GL2, CGUACGCGGAAUACUUCGAUU (CTM-134302, Dharmacon); siMTBP: 1:1 mix of MTBP1,GAGAGAAACAGUUAGCUAA/MTBP2, UCACAUUGUUGGAUGCUAA (J-013953-06-0050 and J-013953-08-0050, Dharmacon); Treslin/TICRRGAACAAAGGTTATCACAAA (custom-made, Dharmacon).
Antibodies
Antibodies against Treslin/TICRR, MTBP, Cdk8-cyclin C, GFP and Flag, as well as HRP-coupled antibodies were described25.
anti-Mcm2 (goat, Santa Cruz (sc-9839)); Chk1 (mouse, Santa Cruz (sc-8404); Chk1 pSer345 (rabbit, Cell Signalling (2348S)).
Immunoprecipitation
Co-immunoprecipitation experiments were done as described previously with the indicated amendments25. In brief, C-terminally 3FLAG-TEV2-GFP tagged MTBP was immunoprecipitated from lysates of a 10 cm tissue culture plate each of transiently transfected 293T cells after lysis in 5 times the pellet volume of lysis buffer (20 mM HEPES, 300 mM NaCl, 5 mM EDTA, 10% Glycerol, complete EDTA-free protease inhibitor cocktail (Roche, 05056489001), 0,1% Triton X100, 2 mM 2-mercaptoethanol). Lysates were incubated with 20 µg anti-GFP nanobodies covalently coupled to 10 µl NHS sepharose (GE Healthcare, 10343240). After incubation for 2 h at 4 °C the immunoprecipitates were washed with lysis buffer and retained proteins eluted by boiling in Laemmli sample buffer.
For immunoprecipitations of C-terminally 3FLAG-TEV2-GFP tagged MTBP from 293T cells for in vitro phosphorylation of MTBP a 15 cm plate of transiently transfected 293T cells were lysed in 5 × pellet volume of lysis buffer (replacing EDTA with EGTA). After incubation for 2 h at 4 °C the immunoprecipitates were used for in vitro kinase assays.
Chromatin preparation
Chromatin-enriched fractions were purified from HeLa Flip-In T-Rex cell lines as described25.
Purification of 6His-Treslin/TICRR-aa1-1258-MTBP-strep complex
Two liters of Sf9 insect cells were co-infected with the individual viruses for pLib-6xHis-Treslin/TICRR-1-1258 and pLib-MTBP-Strep. 72 h after infection, cells were lysed in 120 ml of lysis buffer (20 mM HEPES pH 8.0, 500 mM NaCl, 0.1% Tween20, 25 mM Imidazole, 0.5 mM TCEP, protease inhibitor cocktail (Roche Complete protease inhibitor cocktail, 05056489001)). The lysate was centrifuged at 44,800×g for 30 min and the supernatant was incubated with Strep-Tactin agarose beads for 1 h at 4 °C. After three washes of the beads with washing buffer (20 mM HEPES pH 8.0, 500 mM NaCl, 0.01% Tween20, 25 mM Imidazole), elution was done with wash buffer supplemented with 2.5 mM desthiobiotin. The eluates were purified over a 1 ml HiTrap HP Ni–NTA column (GE Healthcare), using a linear gradient of from 25 mM to 1 M imidazole in elution buffer (20 mM HEPES pH8.0, 500 mM NaCl, 0.01% Tween20). Peak fractions were pooled.
In vitro phosphorylation of MTBP
For in vitro kinase assays, 500 ng recombinant human 6His-Treslin/TICRR-aa1-1258-MTBP-strep or anti-GFP sepharose-bound MTBP-Flag-GFP immunoprecipitated from transiently transfected 293T cells were incubated at 30 °C for 30 min with kinase buffer (20 mM Hepes pH 8,0, 300 mM NaCl, 13,5 mM MgCl2, 10 mM B-Glycerol-phosphate, 5 mM B-Merc, 20 mM EGTA), 1 µl of recombinant Cdk2-Cyclin A (2 mg/ml)45 or 1 µl of recombinant Chk1 (generous gift from S Jackson) and, where indicated, with DMSO, 200 µM of CDK inhibitor roscovitine or 200 nM of Chk1 inhibitor AZD7762, or 30 µM senexin A in the presence of γ‐32P‐ATP and kinase buffer. For Cdk8/19-cyclin C kinase assays, no recombinant kinase was added. Detection required long exposures for autoradiography or co-transfection of Cdk8 and cyclin C. Laemmli SDS sample buffer was added for SDS PAGE analysis and autoradiography. Quantification of signal intensities and background subtraction were done using Fiji/ImageJ software.
Cell cycle flow cytometry
Pulse-labelling of cells for 15–30 min with 10 µM 5-bromo-2′-deoxyuridine (BrdU) and subsequent detection of BrdU with anti-BrdU-FITC and double stranded DNA with propidium iodide were described25. Flow cytometry analysis was performed using a FACSCalibur (BD Bioscience) or a MACSQuant (Miltenyi Biotec) flow cytometers.
Data analysis was performed using the Kaluza Analysis 1.3 software (Beckman Coulter). Cell aggregates were excluded based on their high FL2-W signal. BrdU-PI profiles were generated as density plots. For quantifications of replication activities, the BrdU signal of BrdU-positive S phase cells was background-subtracted using the signal intensity of BrdU-negative G1 and G2/M phase cells to calculate the replication-dependent BrdU signal. For quantifications of the efficiency of replication rescue by MTBP transgenes, the BrdU-replication signal from MTBP/Treslin/TICRR siRNAi treat cells was divided by the BrdU-replication signal of control siRNA treated cells. Visualisation as bar diagrams and statistics was done using GraphPad Prism 5 or 8 (GraphPad Software Inc.).
Radio resistant DNA synthesis (RDS)
HeLa Flip-In T-Rex cells were treated with DMSO or 6 µM ATR inhibitor VE821 for 1 h before being gamma irradiated at 130 kV with a 0.5 mm-Al-filter at a dose rate of 1 Gy/72 s (RX-650 Faxitron) at room temperature. Control cells not irradiated were left outside at room temperature for the duration of the gamma irradiation procedure. Cells were then grown at standard conditions for 1 h (or indicated times) and BrdU-labelled for cell cycle flow cytometry.
DNA combing
Cells were labelled for 20 min each with 20 µM 5-Chloro-2′-deoxyuridine (CldU) and subsequently with 200 µM 5-Iodo-2′-deoxyuridine (IdU). Cells were washed in cold PBS before harvesting with trypsin. Cells were embedded in agarose (8 × 105 cells in 90 µl) before treatment with Proteinase K (Sigma Aldrich, 3115844001) over night at 42 °C followed by washing the agarose plugs in TE 10.1 buffer (10 mM Tris/HCl, pH8, 1 mM EDTA pH8) first three times for 1 h then once for 2 h. Plugs were transferred into 1.5 ml 0,5 M MES and melted at 68 °C for 40 min followed by 20 min at 42 °C before adding 5 µl β-Agarase (NEB, M0393L) to each sample and incubation overnight. DNA was combed on salinized coverslips (Genomic Vision, COV-002-RUO) using the FiberComb machine (Genomic Vision). Combed coverslips were incubated at 70 °C for 2 h. For immunodetection, DNA was denatured with 0,5 M NaOH/1 M NaCl solution for 8 min at RT. After 3 washing steps with 1XDPBS (LifeTechnologies, 14190169) the coverslips were dehydrated using successive 1 min washes with 70%, 90% and 100% ethanol. After drying the coverslips were incubated with 25 µl Block Aid solution (Invitrogen, B10710) on a glass slide. Antibody incubation was performed as followed, indicated amounts were used per coverslip: 1st antibody (4 µl mouse anti-BrdU (anti-BrdU, clone B44, BD Bioscience, 347580) + 2 µl rat anti-BrdU (Bio-Rad, OBT0030G) in 19 µl Block Aid) for 1 h at 37 °C, 2nd antibody (2 µl goat anti-mouse Cy3 (Abcam, AB6946) + 2 µl goat anti-rat Cy5 (Abcam, AB6565) in 21 µl Block Aid) for 45 min at 37 °C, 3rd antibody (4 µl mouse anti-ssDNA (http://dshb.biology.uiowa.edu/autoimmune-ssDNA) in 21 µl Block Aid) for 2 h at 37 °C, 4th antibody (2 µl goat anti-mouse BV480 (Jackson Immuno Research, 115-685-166) in 23 µl Block Aid) for 45 min at 37 °C. Between antibody incubations coverslips were washed 3 times with 1xPBS, 0.05% Tween for 3 min at 100 rpm on an orbital shaker.
Coverslips were then dehydrated by successive incubations in 70%, 90% and 100% ethanol. Image acquisition was performed using the FiberVision scanner (Genomic Vision). Each coverslip was mounted onto a barcoded coverslip carrier (Genomic Vision S.A., 92220 Bagneux. France) and imaged using the Fiber Vision fluorescent microscope (Genomic Vision). Fluorescence imaging was performed automatically using the “RCA standard” program. Data analysis was performed using the web-based FiberStudio software (Genomic Vision, Version 2.0.2). The automated imaging creates merges of the fluorescent channels that were used for subsequent analysis. For fork speed analysis more than 100 structures were validated after visual confirmation of the automated assignment of the FiberStudio Software. For IOD at least 50 inter-origin-distances were measured by only validation of intact structures that were flanked by intact DNA on both sides.
The structures were categorized in origin of replication, termination of replication or ongoing forks. For IOD, mean distance between two adjacent origins in intact fibers was calculated. For fork speed, mean length of intact labeled forks was measured and divided by labeling time. 2 or more replicates were done and the average of the means were calculated for each condition.
Data availability
The authors will comply with Nature Research policies for the sharing of research materials and data.
References
Macheret, M. & Halazonetis, T. D. DNA replication stress as a hallmark of cancer. Annu. Rev. Pathol. 10, 425–448. https://doi.org/10.1146/annurev-pathol-012414-040424 (2015).
McIntosh, D. & Blow, J. J. Dormant origins, the licensing checkpoint, and the response to replicative stresses. Cold Spring Harb. Perspect. Biol. https://doi.org/10.1101/cshperspect.a012955 (2012).
Kawabata, T. et al. Stalled fork rescue via dormant replication origins in unchallenged S phase promotes proper chromosome segregation and tumor suppression. Mol. Cell 41, 543–553. https://doi.org/10.1016/j.molcel.2011.02.006 (2011).
Shima, N. et al. A viable allele of Mcm4 causes chromosome instability and mammary adenocarcinomas in mice. Nat. Genet. 39, 93–98. https://doi.org/10.1038/ng1936 (2007).
Hyrien, O., Marheineke, K. & Goldar, A. Paradoxes of eukaryotic DNA replication: MCM proteins and the random completion problem. BioEssays 25, 116–125 (2003).
Maya-Mendoza, A. et al. High speed of fork progression induces DNA replication stress and genomic instability. Nature 559, 279–284. https://doi.org/10.1038/s41586-018-0261-5 (2018).
Mantiero, D., Mackenzie, A., Donaldson, A. & Zegerman, P. Limiting replication initiation factors execute the temporal programme of origin firing in budding yeast. EMBO J. 30, 4805–4814. https://doi.org/10.1038/emboj.2011.404 (2011).
Tanaka, S., Nakato, R., Katou, Y., Shirahige, K. & Araki, H. Origin association of Sld3, Sld7, and Cdc45 proteins is a key step for determination of origin-firing timing. Curr. Biol. 21, 2055–2063. https://doi.org/10.1016/j.cub.2011.11.038 (2011).
Collart, C., Allen, G. E., Bradshaw, C. R., Smith, J. C. & Zegerman, P. Titration of four replication factors is essential for the Xenopus laevis midblastula transition. Science 341, 893–896. https://doi.org/10.1126/science.1241530 (2013).
Macheret, M. & Halazonetis, T. D. Intragenic origins due to short G1 phases underlie oncogene-induced DNA replication stress. Nature 555, 112–116. https://doi.org/10.1038/nature25507 (2018).
Helmrich, A., Ballarino, M., Nudler, E. & Tora, L. Transcription-replication encounters, consequences and genomic instability. Nat. Struct. Mol. Biol. 20, 412–418. https://doi.org/10.1038/nsmb.2543 (2013).
Siddiqui, K., On, K. F. & Diffley, J. F. Regulating DNA replication in eukarya. Cold Spring Harb. Perspect. Biol. https://doi.org/10.1101/cshperspect.a012930 (2013).
Zou, L. & Stillman, B. Assembly of a complex containing Cdc45p, replication protein A, and Mcm2p at replication origins controlled by S-phase cyclin-dependent kinases and Cdc7p-Dbf4p kinase. Mol. Cell. Biol. 20, 3086–3096 (2000).
Heller, R. C. et al. Eukaryotic origin-dependent DNA replication in vitro reveals sequential action of DDK and S-CDK kinases. Cell 146, 80–91. https://doi.org/10.1016/j.cell.2011.06.012 (2011).
Deegan, T. D., Yeeles, J. T. & Diffley, J. F. Phosphopeptide binding by Sld3 links Dbf4-dependent kinase to MCM replicative helicase activation. EMBO J. 35, 961–973. https://doi.org/10.15252/embj.201593552 (2016).
Kamimura, Y., Tak, Y. S., Sugino, A. & Araki, H. Sld3, which interacts with Cdc45 (Sld4), functions for chromosomal DNA replication in Saccharomyces cerevisiae. Embo J. 20, 2097–2107 (2001).
Miyazawa-Onami, M., Araki, H. & Tanaka, S. Pre-initiation complex assembly functions as a molecular switch that splits the Mcm2-7 double hexamer. EMBO Rep. 18, 1752–1761. https://doi.org/10.15252/embr.201744206 (2017).
Zegerman, P. & Diffley, J. F. X. Phosphorylation of Sld2 and Sld3 by cyclin-dependent kinases promotes DNA replication in budding yeast. Nature 445, 281–285. https://doi.org/10.1038/nature05432 (2007).
Tanaka, S. et al. CDK-dependent phosphorylation of Sld2 and Sld3 initiates DNA replication in budding yeast. Nature 445, 328–332. https://doi.org/10.1038/nature05465 (2007).
Yeeles, J. T., Deegan, T. D., Janska, A., Early, A. & Diffley, J. F. Regulated eukaryotic DNA replication origin firing with purified proteins. Nature 519, 431–435. https://doi.org/10.1038/nature14285 (2015).
Goswami, P. et al. Structure of DNA-CMG-Pol epsilon elucidates the roles of the non-catalytic polymerase modules in the eukaryotic replisome. Nat. Commun. 9, 5061. https://doi.org/10.1038/s41467-018-07417-1 (2018).
Langston, L. D. et al. CMG helicase and DNA polymerase epsilon form a functional 15-subunit holoenzyme for eukaryotic leading-strand DNA replication. Proc. Natl. Acad. Sci. USA 111, 15390–15395. https://doi.org/10.1073/pnas.1418334111 (2014).
Ilves, I., Petojevic, T., Pesavento, J. J. & Botchan, M. R. Activation of the MCM2-7 helicase by association with Cdc45 and GINS proteins. Mol. Cell. 37, 247–258. https://doi.org/10.1016/j.molcel.2009.12.030 (2010).
Douglas, M. E., Ali, F. A., Costa, A. & Diffley, J. F. X. The mechanism of eukaryotic CMG helicase activation. Nature 555, 265–268. https://doi.org/10.1038/nature25787 (2018).
Kohler, K. et al. The Cdk8/19-cyclin C transcription regulator functions in genome replication through metazoan Sld7. PLoS Biol. 17, e2006767. https://doi.org/10.1371/journal.pbio.2006767 (2019).
Kumagai, A. & Dunphy, W. G. MTBP, the Partner of Treslin, contains a novel DNA-binding domain that is essential for proper initiation of DNA replication. Mol. Biol. Cell https://doi.org/10.1091/mbc.E17-07-0448 (2017).
Tanaka, T. et al. Sld7, an Sld3-associated protein required for efficient chromosomal DNA replication in budding yeast. EMBO J. https://doi.org/10.1038/emboj.2011.115 (2011).
Itou, H., Shirakihara, Y. & Araki, H. The quaternary structure of the eukaryotic DNA replication proteins Sld7 and Sld3. Acta Crystallogr. D 71, 1649–1656. https://doi.org/10.1107/S1399004715010457 (2015).
Sheu, Y. J. & Stillman, B. Cdc7-Dbf4 phosphorylates MCM proteins via a docking site-mediated mechanism to promote S phase progression. Mol. Cell 24, 101–113. https://doi.org/10.1016/j.molcel.2006.07.033 (2006).
Zegerman, P. & Diffley, J. F. X. Checkpoint-dependent inhibition of DNA replication initiation by Sld3 and Dbf4 phosphorylation. Nature 467, 474–478. https://doi.org/10.1038/nature09373 (2010).
Lopez-Mosqueda, J. et al. Damage-induced phosphorylation of Sld3 is important to block late origin firing. Nature 467, 479–483. https://doi.org/10.1038/nature09377 (2010).
Duch, A. et al. A Dbf4 mutant contributes to bypassing the Rad53-mediated block of origins of replication in response to genotoxic stress. J. Biol. Chem. 286, 2486–2491. https://doi.org/10.1074/jbc.M110.190843 (2011).
Brummer, A., Salazar, C., Zinzalla, V., Alberghina, L. & Hofer, T. Mathematical modelling of DNA replication reveals a trade-off between coherence of origin activation and robustness against rereplication. PLoS Comput. Biol. 6, e1000783. https://doi.org/10.1371/journal.pcbi.1000783 (2010).
Tanaka, S. & Araki, H. Multiple regulatory mechanisms to inhibit untimely initiation of DNA replication are important for stable genome maintenance. PLoS Genet. 7, e1002136. https://doi.org/10.1371/journal.pgen.1002136 (2011).
Reusswig, K. U., Zimmermann, F., Galanti, L. & Pfander, B. Robust replication control is generated by temporal gaps between licensing and firing phases and depends on degradation of firing factor Sld2. Cell. Rep. 17, 556–569. https://doi.org/10.1016/j.celrep.2016.09.013 (2016).
BastosdeOliveira, F. M. et al. Phosphoproteomics reveals distinct modes of Mec1/ATR signaling during DNA replication. Mol. Cell 57, 1124–1132. https://doi.org/10.1016/j.molcel.2015.01.043 (2015).
Shechter, D., Costanzo, V. & Gautier, J. ATR and ATM regulate the timing of DNA replication origin firing. Nat. Cell Biol. 6, 648–655 (2004).
Sokka, M., Koalick, D., Hemmerich, P., Syvaoja, J. E. & Pospiech, H. The ATR-activation domain of TopBP1 is required for the suppression of origin firing during the S phase. Int. J. Mol. Sci. 19, 76. https://doi.org/10.3390/ijms19082376 (2018).
Van Hatten, R. A. et al. The Xenopus Xmus101 protein is required for the recruitment of Cdc45 to origins of DNA replication. J. Cell Biol. 159, 541–547 (2002).
Hashimoto, Y. & Takisawa, H. Xenopus Cut5 is essential for a CDK-dependent process in the initiation of DNA replication. Embo J. 22, 2526–2535 (2003).
Sangrithi, M. N. et al. Initiation of DNA replication requires the RECQL4 protein mutated in Rothmund-Thomson syndrome. Cell 121, 887–898 (2005).
Matsuno, K., Kumano, M., Kubota, Y., Hashimoto, Y. & Takisawa, H. The N-terminal noncatalytic region of Xenopus RecQ4 is required for chromatin binding of DNA polymerase alpha in the initiation of DNA replication. Mol. Cell Biol. 26, 4843–4852 (2006).
Sansam, C. L. et al. A vertebrate gene, ticrr, is an essential checkpoint and replication regulator. Genes Dev. 24, 183–194. https://doi.org/10.1101/gad.1860310 (2010).
Kumagai, A., Shevchenko, A. & Dunphy, W. G. Treslin collaborates with TopBP1 in triggering the initiation of DNA replication. Cell 140, 349–359. https://doi.org/10.1016/j.cell.2009.12.049 (2010).
Boos, D. et al. Regulation of DNA replication through Sld3-Dpb11 interaction is conserved from yeast to humans. Curr. Biol. 21, 1152–1157. https://doi.org/10.1016/j.cub.2011.05.057 (2011).
Kumagai, A., Shevchenko, A. & Dunphy, W. G. Direct regulation of Treslin by cyclin-dependent kinase is essential for the onset of DNA replication. J. Cell. Biol. 193, 995–1007. https://doi.org/10.1083/jcb.201102003 (2011).
Charrasse, S. et al. Ensa controls S-phase length by modulating Treslin levels. Nat. Commun. 8, 206. https://doi.org/10.1038/s41467-017-00339-4 (2017).
Guo, C. et al. Interaction of Chk1 with Treslin negatively regulates the initiation of chromosomal DNA replication. Mol. Cell 57, 492–505. https://doi.org/10.1016/j.molcel.2014.12.003 (2015).
Sansam, C. G. et al. A mechanism for epigenetic control of DNA replication. Genes Dev. 32, 224–229. https://doi.org/10.1101/gad.306464.117 (2018).
Boos, D., Yekezare, M. & Diffley, J. F. Identification of a heteromeric complex that promotes DNA replication origin firing in human cells. Science 340, 981–984. https://doi.org/10.1126/science.1237448 (2013).
Boyd, M. T., Vlatkovic, N. & Haines, D. S. A novel cellular protein (MTBP) binds to MDM2 and induces a G1 arrest that is suppressed by MDM2. J. Biol. Chem. 275, 31883–31890 (2000).
Brady, M., Vlatkovic, N. & Boyd, M. T. Regulation of p53 and MDM2 activity by MTBP. Mol. Cell Biol. 25, 545–553. https://doi.org/10.1128/MCB.25.2.545-553.2005 (2005).
Agarwal, N. et al. MTBP plays a crucial role in mitotic progression and chromosome segregation. Cell Death Differ. 18, 1208–1219. https://doi.org/10.1038/cdd.2010.189 (2011).
Agarwal, N. et al. MTBP suppresses cell migration and filopodia formation by inhibiting ACTN4. Oncogene https://doi.org/10.1038/onc.2012.69 (2012).
Grieb, B. C. et al. Oncogenic protein MTBP interacts with MYC to promote tumorigenesis. Cancer Res. 74, 3591–3602. https://doi.org/10.1158/0008-5472.CAN-13-2149 (2014).
Odvody, J. et al. A deficiency in Mdm2 binding protein inhibits Myc-induced B-cell proliferation and lymphomagenesis. Oncogene 29, 3287–3296. https://doi.org/10.1038/onc.2010.82 (2010).
Iwakuma, T. et al. Mtbp haploinsufficiency in mice increases tumor metastasis. Oncogene 27, 1813–1820. https://doi.org/10.1038/sj.onc.1210827 (2008).
Mertins, P. et al. Integrated proteomic analysis of post-translational modifications by serial enrichment. Nat. Methods 10, 634–637. https://doi.org/10.1038/nmeth.2518 (2013).
Udeshi, N. D. et al. Refined preparation and use of anti-diglycine remnant (K-epsilon-GG) antibody enables routine quantification of 10,000s of ubiquitination sites in single proteomics experiments. Mol. Cell. Proteom. 12, 825–831. https://doi.org/10.1074/mcp.O112.027094 (2013).
Wagner, S. A. et al. A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol. Cell. Proteom. https://doi.org/10.1074/mcp.M111.013284 (2011).
Akimov, V. et al. UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat. Struct. Mol. Biol. 25, 631–640. https://doi.org/10.1038/s41594-018-0084-y (2018).
Hendriks, I. A. et al. Uncovering global SUMOylation signaling networks in a site-specific manner. Nat. Struct. Mol. Biol. 21, 927–936. https://doi.org/10.1038/nsmb.2890 (2014).
Dephoure, N. et al. A quantitative atlas of mitotic phosphorylation. Proc. Natl. Acad. Sci. USA 105, 10762–10767. https://doi.org/10.1073/pnas.0805139105 (2008).
Mayya, V. et al. Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci. Signal. https://doi.org/10.1126/scisignal.2000007 (2009).
Sharma, K. et al. Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell. Rep. 8, 1583–1594. https://doi.org/10.1016/j.celrep.2014.07.036 (2014).
Kettenbach, A. N. et al. Quantitative phosphoproteomics identifies substrates and functional modules of aurora and polo-like kinase activities in mitotic cells. Sci. Signal. https://doi.org/10.1126/scisignal.2001497 (2011).
Grimsrud, P. A. et al. A quantitative map of the liver mitochondrial phosphoproteome reveals posttranslational control of ketogenesis. Cell. Metab. 16, 672–683. https://doi.org/10.1016/j.cmet.2012.10.004 (2012).
Mertins, P. et al. Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol. Cell. Proteom. 13, 1690–1704. https://doi.org/10.1074/mcp.M113.036392 (2014).
Montagnoli, A. et al. Identification of Mcm2 phosphorylation sites by S-phase-regulating kinases. J. Biol. Chem. 281, 10281–10290 (2006).
Iwai, K. et al. Molecular mechanism and potential target indication of TAK-931, a novel CDC7-selective inhibitor. Sci. Adv. 5, eaav3660. https://doi.org/10.1126/sciadv.aav3660 (2019).
Randell, J. C. et al. Mec1 is one of multiple kinases that prime the Mcm2-7 helicase for phosphorylation by Cdc7. Mol. Cell 40, 353–363. https://doi.org/10.1016/j.molcel.2010.10.017 (2010).
Sheu, Y. J. & Stillman, B. The Dbf4-Cdc7 kinase promotes S phase by alleviating an inhibitory activity in Mcm4. Nature 463, 113–117. https://doi.org/10.1038/nature08647 (2010).
Sansam, C. G., Goins, D., Siefert, J. C., Clowdus, E. A. & Sansam, C. L. Cyclin-dependent kinase regulates the length of S phase through TICRR/TRESLIN phosphorylation. Genes Dev. 29, 555–566. https://doi.org/10.1101/gad.246827.114 (2015).
Liu, T. et al. A divergent role of the SIRT1-TopBP1 axis in regulating metabolic checkpoint and DNA damage checkpoint. Mol. Cell 56, 681–695. https://doi.org/10.1016/j.molcel.2014.10.007 (2014).
Hiraga, S. et al. Rif1 controls DNA replication by directing Protein Phosphatase 1 to reverse Cdc7-mediated phosphorylation of the MCM complex. Genes Dev. 28, 372–383. https://doi.org/10.1101/gad.231258.113 (2014).
Dave, A., Cooley, C., Garg, M. & Bianchi, A. Protein phosphatase 1 recruitment by Rif1 regulates DNA replication origin firing by counteracting DDK activity. Cell. Rep. 7, 53–61. https://doi.org/10.1016/j.celrep.2014.02.019 (2014).
Mattarocci, S. et al. Rif1 controls DNA replication timing in yeast through the PP1 phosphatase Glc7. Cell. Rep. 7, 62–69. https://doi.org/10.1016/j.celrep.2014.03.010 (2014).
Poh, W. T., Chadha, G. S., Gillespie, P. J., Kaldis, P. & Blow, J. J. Xenopus Cdc7 executes its essential function early in S phase and is counteracted by checkpoint-regulated protein phosphatase 1. Open Biol. 4, 130138. https://doi.org/10.1098/rsob.130138 (2014).
Alver, R. C., Chadha, G. S., Gillespie, P. J. & Blow, J. J. Reversal of DDK-mediated MCM phosphorylation by Rif1-PP1 regulates replication initiation and replisome stability independently of ATR/Chk1. Cell. Rep. 18, 2508–2520. https://doi.org/10.1016/j.celrep.2017.02.042 (2017).
Fahrenkamp, D., de Leur, H. S., Kuster, A., Chatain, N. & Muller-Newen, G. Src family kinases interfere with dimerization of STAT5A through a phosphotyrosine-SH2 domain interaction. Cell. Commun. Signal 13, 10. https://doi.org/10.1186/s12964-014-0081-7 (2015).
Acknowledgements
We would like to thank the lab of S Westermann for scientific discussion and sharing technical expertise. We also thank Arnaud Rondelet and A Bird for expertise on cell culture techniques. J Forment and S Jackson kindly provided recombinant Chk1.
Funding
Open Access funding enabled and organized by Projekt DEAL. This article was funded by Ministerium für Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen (NRW Rueckkehrerfoerderprogramm), José Carreras Leukämie-Stiftung (DJCLS R15/23) and Deutsche Forschungsgemeinschaft (GRK1739).
Author information
Authors and Affiliations
Contributions
Conception and design: D.B.; Development of methodology: P.F., V.H., K.K., C.D., K.U.R., J.A., N.S., D.B.; Acquisition of data: P.F., V.H., N.K., A.M., N.T., D.B.; Analysis and interpretation of data: P.F., V.H., N.K., K.K., K.U.R, C.D., B.P., D.B.; Writing and reviewing of the manuscript: D.B., P.F. (writing), K.U.R, B.P. (reviewing); Material support: B.T.; Study supervision: D.B.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Ferreira, P., Höfer, V., Kronshage, N. et al. MTBP phosphorylation controls DNA replication origin firing. Sci Rep 11, 4242 (2021). https://doi.org/10.1038/s41598-021-83287-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-021-83287-w
- Springer Nature Limited
This article is cited by
-
TopBP1 utilises a bipartite GINS binding mode to support genome replication
Nature Communications (2024)
-
Rif1 restrains the rate of replication origin firing in Xenopus laevis
Communications Biology (2023)
-
Aberrant R-loop-induced replication stress in MED12-mutant uterine fibroids
Scientific Reports (2022)